Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Bryan Schneider, Lang Li, Milan Radovich, Fei Shen, Kathy Miller, David A. Flockhart, Guanglong Jiang, Gail Vance, Laura Gardner, Matteo Vatta, Shaochun Bai, Dongbing Lai, Daniel Koller, Fengmin Zhao, Anne O'Neill, Mary Lou Smith, Elda Railey, Carol White, Ann Partridge, Joseph Sparano & 3 others Nancy E. Davidson, Tatiana Foroud, George W. Sledge

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Purpose: Taxane-induced peripheral neuropathy (TIPN) is an important survivorship issue for many cancer patients. Currently, there are no clinically implemented biomarkers to predict which patients might be at increased risk for TIPN. We present a comprehensive approach to identification of genetic variants to predict TIPN. Experimental Design: We performed a genome-wide association study (GWAS) in 3,431 patients from the phase III adjuvant breast cancer trial, ECOG-5103 to compare genotypes with TIPN. We performed candidate validation of top SNPs for TIPN in another phase III adjuvant breast cancer trial, ECOG-1199. Results: When evaluating for grade 3?4 TIPN, 120 SNPs had a P value of 10-4 from patients of European descent (EA) in ECOG- 5103. Thirty candidate SNPs were subsequently tested in ECOG- 1199 and SNP rs3125923 was found to be significantly associated with grade 3?4 TIPN (P = 1.7 × 10-3; OR, 1.8). Race was also a major predictor of TIPN, with patients of African descent (AA) experiencing increased risk of grade 2?4 TIPN (HR, 2.1; P = 5.6 × 10-16) and grade 3?4 TIPN(HR, 2.6; P = 1.1 × 10-11) compared with others. An SNP in FCAMR, rs1856746, had a trend toward an association with grade 2?4 TIPN in AA patients from the GWAS in ECOG-5103 (OR, 5.5; P = 1.6 × 10-7). Conclusions: rs3125923 represents a validated SNP to predict grade 3-4 TIPN. Genetically determined AA race represents the most significant predictor of TIPN.

Original languageEnglish (US)
Pages (from-to)5082-5091
Number of pages10
JournalClinical Cancer Research
Volume21
Issue number22
DOIs
StatePublished - Nov 15 2015

Fingerprint

Genome-Wide Association Study
Peripheral Nervous System Diseases
Single Nucleotide Polymorphism
taxane
Breast Neoplasms
Research Design
Survival Rate
Biomarkers
Genotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199. / Schneider, Bryan; Li, Lang; Radovich, Milan; Shen, Fei; Miller, Kathy; Flockhart, David A.; Jiang, Guanglong; Vance, Gail; Gardner, Laura; Vatta, Matteo; Bai, Shaochun; Lai, Dongbing; Koller, Daniel; Zhao, Fengmin; O'Neill, Anne; Smith, Mary Lou; Railey, Elda; White, Carol; Partridge, Ann; Sparano, Joseph; Davidson, Nancy E.; Foroud, Tatiana; Sledge, George W.

In: Clinical Cancer Research, Vol. 21, No. 22, 15.11.2015, p. 5082-5091.

Research output: Contribution to journalArticle

Schneider, B, Li, L, Radovich, M, Shen, F, Miller, K, Flockhart, DA, Jiang, G, Vance, G, Gardner, L, Vatta, M, Bai, S, Lai, D, Koller, D, Zhao, F, O'Neill, A, Smith, ML, Railey, E, White, C, Partridge, A, Sparano, J, Davidson, NE, Foroud, T & Sledge, GW 2015, 'Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199', Clinical Cancer Research, vol. 21, no. 22, pp. 5082-5091. https://doi.org/10.1158/1078-0432.CCR-15-0586
Schneider, Bryan ; Li, Lang ; Radovich, Milan ; Shen, Fei ; Miller, Kathy ; Flockhart, David A. ; Jiang, Guanglong ; Vance, Gail ; Gardner, Laura ; Vatta, Matteo ; Bai, Shaochun ; Lai, Dongbing ; Koller, Daniel ; Zhao, Fengmin ; O'Neill, Anne ; Smith, Mary Lou ; Railey, Elda ; White, Carol ; Partridge, Ann ; Sparano, Joseph ; Davidson, Nancy E. ; Foroud, Tatiana ; Sledge, George W. / Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199. In: Clinical Cancer Research. 2015 ; Vol. 21, No. 22. pp. 5082-5091.
@article{1653eedf4b534a6584cd0a9754f3e3d7,
title = "Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199",
abstract = "Purpose: Taxane-induced peripheral neuropathy (TIPN) is an important survivorship issue for many cancer patients. Currently, there are no clinically implemented biomarkers to predict which patients might be at increased risk for TIPN. We present a comprehensive approach to identification of genetic variants to predict TIPN. Experimental Design: We performed a genome-wide association study (GWAS) in 3,431 patients from the phase III adjuvant breast cancer trial, ECOG-5103 to compare genotypes with TIPN. We performed candidate validation of top SNPs for TIPN in another phase III adjuvant breast cancer trial, ECOG-1199. Results: When evaluating for grade 3?4 TIPN, 120 SNPs had a P value of 10-4 from patients of European descent (EA) in ECOG- 5103. Thirty candidate SNPs were subsequently tested in ECOG- 1199 and SNP rs3125923 was found to be significantly associated with grade 3?4 TIPN (P = 1.7 × 10-3; OR, 1.8). Race was also a major predictor of TIPN, with patients of African descent (AA) experiencing increased risk of grade 2?4 TIPN (HR, 2.1; P = 5.6 × 10-16) and grade 3?4 TIPN(HR, 2.6; P = 1.1 × 10-11) compared with others. An SNP in FCAMR, rs1856746, had a trend toward an association with grade 2?4 TIPN in AA patients from the GWAS in ECOG-5103 (OR, 5.5; P = 1.6 × 10-7). Conclusions: rs3125923 represents a validated SNP to predict grade 3-4 TIPN. Genetically determined AA race represents the most significant predictor of TIPN.",
author = "Bryan Schneider and Lang Li and Milan Radovich and Fei Shen and Kathy Miller and Flockhart, {David A.} and Guanglong Jiang and Gail Vance and Laura Gardner and Matteo Vatta and Shaochun Bai and Dongbing Lai and Daniel Koller and Fengmin Zhao and Anne O'Neill and Smith, {Mary Lou} and Elda Railey and Carol White and Ann Partridge and Joseph Sparano and Davidson, {Nancy E.} and Tatiana Foroud and Sledge, {George W.}",
year = "2015",
month = "11",
day = "15",
doi = "10.1158/1078-0432.CCR-15-0586",
language = "English (US)",
volume = "21",
pages = "5082--5091",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

AU - Schneider, Bryan

AU - Li, Lang

AU - Radovich, Milan

AU - Shen, Fei

AU - Miller, Kathy

AU - Flockhart, David A.

AU - Jiang, Guanglong

AU - Vance, Gail

AU - Gardner, Laura

AU - Vatta, Matteo

AU - Bai, Shaochun

AU - Lai, Dongbing

AU - Koller, Daniel

AU - Zhao, Fengmin

AU - O'Neill, Anne

AU - Smith, Mary Lou

AU - Railey, Elda

AU - White, Carol

AU - Partridge, Ann

AU - Sparano, Joseph

AU - Davidson, Nancy E.

AU - Foroud, Tatiana

AU - Sledge, George W.

PY - 2015/11/15

Y1 - 2015/11/15

N2 - Purpose: Taxane-induced peripheral neuropathy (TIPN) is an important survivorship issue for many cancer patients. Currently, there are no clinically implemented biomarkers to predict which patients might be at increased risk for TIPN. We present a comprehensive approach to identification of genetic variants to predict TIPN. Experimental Design: We performed a genome-wide association study (GWAS) in 3,431 patients from the phase III adjuvant breast cancer trial, ECOG-5103 to compare genotypes with TIPN. We performed candidate validation of top SNPs for TIPN in another phase III adjuvant breast cancer trial, ECOG-1199. Results: When evaluating for grade 3?4 TIPN, 120 SNPs had a P value of 10-4 from patients of European descent (EA) in ECOG- 5103. Thirty candidate SNPs were subsequently tested in ECOG- 1199 and SNP rs3125923 was found to be significantly associated with grade 3?4 TIPN (P = 1.7 × 10-3; OR, 1.8). Race was also a major predictor of TIPN, with patients of African descent (AA) experiencing increased risk of grade 2?4 TIPN (HR, 2.1; P = 5.6 × 10-16) and grade 3?4 TIPN(HR, 2.6; P = 1.1 × 10-11) compared with others. An SNP in FCAMR, rs1856746, had a trend toward an association with grade 2?4 TIPN in AA patients from the GWAS in ECOG-5103 (OR, 5.5; P = 1.6 × 10-7). Conclusions: rs3125923 represents a validated SNP to predict grade 3-4 TIPN. Genetically determined AA race represents the most significant predictor of TIPN.

AB - Purpose: Taxane-induced peripheral neuropathy (TIPN) is an important survivorship issue for many cancer patients. Currently, there are no clinically implemented biomarkers to predict which patients might be at increased risk for TIPN. We present a comprehensive approach to identification of genetic variants to predict TIPN. Experimental Design: We performed a genome-wide association study (GWAS) in 3,431 patients from the phase III adjuvant breast cancer trial, ECOG-5103 to compare genotypes with TIPN. We performed candidate validation of top SNPs for TIPN in another phase III adjuvant breast cancer trial, ECOG-1199. Results: When evaluating for grade 3?4 TIPN, 120 SNPs had a P value of 10-4 from patients of European descent (EA) in ECOG- 5103. Thirty candidate SNPs were subsequently tested in ECOG- 1199 and SNP rs3125923 was found to be significantly associated with grade 3?4 TIPN (P = 1.7 × 10-3; OR, 1.8). Race was also a major predictor of TIPN, with patients of African descent (AA) experiencing increased risk of grade 2?4 TIPN (HR, 2.1; P = 5.6 × 10-16) and grade 3?4 TIPN(HR, 2.6; P = 1.1 × 10-11) compared with others. An SNP in FCAMR, rs1856746, had a trend toward an association with grade 2?4 TIPN in AA patients from the GWAS in ECOG-5103 (OR, 5.5; P = 1.6 × 10-7). Conclusions: rs3125923 represents a validated SNP to predict grade 3-4 TIPN. Genetically determined AA race represents the most significant predictor of TIPN.

UR - http://www.scopus.com/inward/record.url?scp=84954116658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954116658&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-15-0586

DO - 10.1158/1078-0432.CCR-15-0586

M3 - Article

VL - 21

SP - 5082

EP - 5091

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 22

ER -